Neuroprotective effects of curcumin against rats with focal cerebral ischemia-reperfusion injury

  • Authors:
    • Lu Xu
    • Ling Ding
    • Yuanqi Su
    • Ruyue Shao
    • Jie Liu
    • Yan Huang
  • View Affiliations

  • Published online on: February 11, 2019     https://doi.org/10.3892/ijmm.2019.4094
  • Pages: 1879-1887
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to investigate the protective effects of curcumin and its effect on the methyl ethyl ketone/extracellular signal regulated kinase/cAMP‑response element binding protein (MEK/ERK/CREB) pathway. The study was conducted in vivo and in vitro as follows: In vivo: Focal cerebral ischemia‑reperfusion (IR) models of rats were made with the plug‑line method. Adult male Sprague‑Dawley rats were divided into four groups: Sham operation control group, IR and curcumin‑treatment groups (100 mg/kg and IC, 300 mg/kg). The effects of curcumin on neurological deficit scores, brain water content and infarct volumes were identified. Transmission electron microscope was utilized to observe morphological changes of hippocampal neurons; hematoxylin and eosin staining was used to observe morphological changes of brain tissue; and the terminal deoxynucleotidyl transferase (TdT)‑mediated dUTP nick end labeling method detected neurons apoptosis of hippocampal CA1. Finally, western blot analysis detected the expression of phosphorylated (p)‑MEK, p‑ERK, p‑CREB, B‑cell lymphoma‑2 (Bcl‑2) and Bcl‑2 associated X protein (Bax). In vitro: An oxygen‑glucose deprivation/reoxygenation method was used on primary cultured astrocytes to make cerebral ischemia‑reperfusion models in vitro. Astrocytes were randomly divided into five groups: Normoxia, oxygen‑glucose deprivation/reoxygenation (OGD/Reoxy), OGD/Reoxy + curcumin (5, 10, 20 µmol/l). The cell viability and toxicity were assessed by MTT and lactate dehydrogenase release assay, and levels of p‑MEK, p‑ERK and p‑CREB proteins were analyzed by the western blotting method. Curcumin was demonstrated to improve nerve damage symptoms and infarct volume, reduce brain water content, relieve neuronal apoptosis and also increase the expression of p‑MEK, p‑ERK, p‑CREB, Bcl‑2 and reduce Bax levels in vivo and in vitro. In conclusion curcumin can mitigate focal cerebral ischemia‑reperfusion injuries and this effect may be carried out through the MEK/ERK/CREB pathway.

Introduction

Approximately 5 million fatalities globally are attributed to stroke each year. Ischemic stroke accounts for more than 80% of total stroke cases and is one of the main causes of mortality and disability worldwide (1-4). Following a period of ischemia, severe reperfusion injury occurs when blood returns to the brain. Reperfusion therefore serves a critical role in cerebral ischemia (5). In clinical treatment, thrombolytic therapy is the only method approved for the treatment of ischemic stroke (6,7). However, restoration of blood flow following thrombolytic treatment may cause severe ischemia-reperfusion injury (8). Currently, the neuroprotective approach has become a novel direction in the treatment of stroke and has been studied in animal experiments, but the efficacy on patients remains limited (9). Consequently, there is an urgent need to develop an effective neuroprotective agent for the prevention and treatment of stroke.

In acute ischemic stroke, apoptosis has been considered one of the main causes of neuronal death (10,11). Apoptosis is evident in animal models and in patients of ischemic stroke. Therefore, inhibition of apoptotic pathways and the creation of a neuroprotective environment provide a potential therapeutic approach for ischemic brain damage. Mitogen activated protein kinase (MAPK) is one of the distinct signaling cascades involved in neuroprotection and is activated during the ischemic process (12). MAPK signaling pathway is activated then causes extracellular signal regulated kinase (ERK) phosphorylation induced by methyl ethyl ketone (MEK) (13). It has been demonstrated that activation of MEK/ERK elicits an anti-apoptosis effect during cerebral ischemia (14). cAMP-response element binding protein (CREB) is a typical protein that possesses anti-apoptotic properties (15). Down-modulation of the MEK/ERK pathways inhibits the phosphorylation of CREB, which causes B-cell lymphoma-2 (Bcl-2) family transcription and expression downregulation and sensitization to cell apoptosis (16).

Curcumin (Cur) was extracted from the rhizome of Curcuma genus plants (17). Cur has anti-inflammatory, antioxidant, anti-apoptotic and other pharmacological effects (18). In cerebral ischemia-reperfusion injury, Cur is also known to have neuroprotective properties (19). However, the underlying molecular mechanisms are still poorly understood. In this study, the aim was to investigate whether Cur protected the brain from ischemic injury by the MEK/ERK/CREB pathway during in vivo and in vitro experiments. The results of the present study will inform future investigations into the neuroprotective effects of curcumin on the molecular level.

Materials and methods

Materials and reagents

Cur was purchased from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany). Antibodies against phosphorylated anti-(p)-MEK), anti-MEK, anti-p-ERK, anti-ERK, anti-CREB, anti-p-CREB, B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), β-actin antibodies and horseradish peroxidase (HRP)-conjugated secondary antibodies were all provided by Sigma-Aldrich (Merck KGaA). Terminal dexynucleotidyl transferase (TdT)-mediate d dUTP nick end labeling (TUNEL) assay kits were obtained from Roche Diagnostics (Basel, Switzerland). Lactate dehydrogenase release assay (LDH) kits were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Dulbecco’s modified Eagle media: Nutrient Mixture F-12 (DMEM/F12) medium, fetal calf serum and trypsin were purchased from Hyclone (Logan, UT, USA). Unless otherwise stated, triphenyl tetrazolium chloride (TTC) powder, PBS buffer, paraformaldehyde, western blot reagents, tetrazolium blue tetrazolium bromide (MTT) and all other chemicals used were provided by Sigma Aldrich; Merck KGaA.

Animals

A total of 60 male Sprague-Dawley (SD) rats (280-320 g) for in vivo experiment and a total of 5 SD rats (1-2 days old) for primary astrocyte cell culture were provided by the Experimental Animal Center of Chongqing Medical University (Chongqing, China) Specific Pathogen Free [animal production license no. SCXK (Chongqing) 2011-0001]. Animals were kept in a controlled room with adequate food and water, constant temperature and humidity (22°C and 55%, respectively) as well as a 12/12 h light/dark cycle.

Establishment of the cerebral ischemia-reperfusion model and animal grouping

Experimental protocols were all approved by the Chongqing Medical University’s Institutional Animal Care and Use Committee. Using Longa’s method, focal cerebral ischemia and reperfusion of middle cerebral artery occlusion models of rats were performed. Rats were anesthetized with 4% chloral hydrate through intraperitoneal injection, then an incision in the skin was made to expose the right common carotid artery, internal carotid artery (ICA) and external carotid artery. The right middle cerebral artery occlusion model was established by introducing an embolus through the ICA. The embolus was inserted into the internal carotid artery until the tip reached the origin of the middle cerebral artery (18-22 mm). After 120 min of ischemia, the embolus was removed. After the procedure, the rats recovered in pre-warmed cages. In total, 60 rats were divided into 4 groups randomly as follows: i) Sham operation control group (SC) (n=15); ii) ischemia-reperfusion group (IR) (n=15); iii) Cur-treatment group (IC) receiving cur at 100 mg/kg (n=15); iv) IC receiving Cur at 300 mg/kg (n=15). Pre-treatment with Cur took place 30 min prior to surgery and daily via intraperitoneal injection. The sham group and ischemia-reperfusion group received similar pre-treatment with normal saline.

Evaluation of neurological deficit scores

A total of 24 h following ischemia/reperfusion, the neurological deficit score was examined by referencing the standard 5 point system established by Longa et al (20): i) No obvious signs of deficit (score 0); ii) failure to extend the right forepaw fully (score 1); iii) circling to the right (score 2); iv) falling to the right (score 3); and v) loss of walking abilities (score 4).

Measurement of the brain water content

After evaluation of neurological deficit scores, 3 rats were anesthetized with 4% chloral hydrate via intraperitoneal injection and rapidly decapitated. Brain tissue was removed quickly, followed by the pia mater and brain tissue blood. Tissue wet weight (A) and dry weight (B, tissue was dried in an oven for 24 h) were weighed (accurate to 0.1 mg). Finally, the brain water content was calculated in accordance with the Blliot formula: Brain water content = (A - B)/A ×100%.

Measurement of cerebral infarct volume

Following evaluation of neurological deficit scores, 3 other rats were anesthetized with 4% chloral hydrate via intraperitoneal injection and rapidly decapitated. The brain was removed and coronally sectioned into 2 mm slices, which were placed into 2% TTC solution at 37°C. After 20 min, slices were stained and images were captured with a camera. Noninfarcted areas of the brain tissue were stained red; infarcted areas appeared white. CMIAS-008 image analysis software (Institute of Beijing University of Aeronautics and Astronautics, Beijing, China) was used to calculate the ratio of the infarct size/the total area.

Transmission electron microscopy (TEM) to observe morphological changes of hippocampal neurons

After evaluation of neurological deficit scores, 3 rats were perfused transcardially with 0.9% NaCl and 2.5% glutaraldehyde and rapidly decapitated. Brain tissue sized 1 mm3 were quickly removed and fixed in 2.5% glutaraldehyde at 37°C. After 1 h, specimens were dehydrated with acetone and embedded by Epon812 at 60°C for 24 h. The 60 nm ultrathin sections of the cubes were stained with uranyl acetate and lead citrate at 25°C for 30 min, and then observed under TEM (7100; Hitachi, Tokyo, Japan).

Hematoxylin and eosin staining (H&E) to observe morphological changes of brain tissue

A total of 3 anesthetized rats were perfused transcardially with 0.9% NaCl and 4% paraformaldehyde through the left ventricle and rapidly decapitated. After brains were removed and embedded in paraffin, they were processed into 5-µm-thick slices. Finally, H&E was applied at 25°C for 15 min to the tissue and the pathological changes of cells in hippocampal CA1 region were observed under an optical microscope (Olympus Corporation, Tokyo, Japan).

TUNEL to detect neurons apoptosis in hippocampal CA1

TUNEL was used to detect neuron apoptosis in hippocampal CA1 in according to the TUNEL assay kit protocol. Stained slices with 5-µm-thick were imaged under the optical microscope. The extent of brain damage was then evaluated by apoptotic index, which was the arithmetic mean of positive cells counted in 5 microscopic fields in each CA1 region of the hippocampus section.

Western blot analysis

A total of 24 h following reperfusion, the hippocampal CA1 of remaining three rats in each group was removed and put on ice. Total protein extraction and protein determination was performed with a protein extraction kit (Beyotime Institute of Biotechnology, Shanghai, China). Subsequently, using western blot analysis, the expression of MEK, p-MEK, p-ERK, ERK, CREB, p-CREB, Bcl-2 and Bax was measured. Protein (30 µl) were separated by 12% SDS-PAGE and transferred onto a nitrocellulose membrane. The membrane was blocked with 10% goat serum (Beyotime Institute of Biotechnology) at 25°C for 2 h and the anti-rabbit antibodies against MEK (cat. no. SAB4502407), p-MEK (cat. no. HPA026430), ERK (cat. no. M7927), p-ERK (cat. no. M7927), CREB (cat. no. SAB4500444), p-CREB (cat. no. AV01026), Bcl-2 (cat. no. SAB4500003), and anti-mouse antibodies against Bax (cat. no. B8554) and β-actin (cat. no. A5441) (1:1,000) were added to the membrane overnight at 4°C. After washing, the membranes were incubated with anti-rabbit HRP-conjugated secondary antibodies (cat. no. AP182P; 1:2,000) for 40 min at 37°C. Subsequently, the membranes were processed with an ECL kit (Beyotime Institute of Biotechnology) to detect immune reactivity. Finally, images were analyzed by a Versa Doc Model 3000 (Bio-Rad Laboratories, Inc., Hercules, CA, USA).

Primary astrocyte cell culture

Cerebral cortexes from 1-2 days old SD rats were separated under sterile conditions. The cell suspensions were seeded (2×106 cells/cm2) into culture plates and complete medium was added. Cultured cells were grown in an incubator at 37°C with 5% CO2 and 100% humidity. After 24 h, astrocytes were replaced with new medium and the medium was replaced every three days. After 11 days astrocytes were used for future experiments. The purity of astrocytes was identified as above 95% by fluorescent antibody technical analysis with anti-glial fibrillary acidic protein (anti-GFAP).

Establishment of the cerebral ischemia-reperfusion model in vitro and astrocyte grouping

Astrocytes were seeded at a density of 5×104 into 24-well plates and cultured for 24 h in an incubator (37°C, 5% CO2). Subsequently, cells were divided into the normoxic group, oxygen-glucose deprivation/reoxygenation group (OGD/Reoxy) and OGD/Reoxy + Cur group (OGD/Reoxy + C group) randomly. There were 6 wells in each group. In the MTT and LDH experiments, the OGD/Reoxy + C group has been divided into three doses [5, 10, 20 micromolar (µmol)/liter (l)], and setting 6 duplicate holes in each group. The solubilization of Cur was achieved with dimethyl sulfoxide (DMSO), but the final concentration of DMSO did not exceed 0.1% in the medium. In the drug-administered group, 1,000 µl of complete medium containing the corresponding drug was added, the normal group and the model group cells had 1,000 µl of complete medium containing no drug but containing the same amount of solvent (DMSO) added as the administration group. Cells were cultivated for 24 h in normal medium, then the model group and drug-administered group were modeled: Cells were subjected to hypoxia and hypoglycemia for 2 h and then reoxygenated for 24 h.

Identification of astrocytes

Cell climbing pieces were washed and fixed by 4% paraformaldehyde at 25°C for 20 min. Then cell climbing pieces were blocked with 5% goat serum at 37°C for 1 h, and the primary antibodies against GFAP (cat. no. G3893) (1:50; Sigma-Aldrich; Merck KGaA) were added overnight at 4°C. After washing, the cell climbing samples were incubated with appropriate fluorescein isothiocyanate fluorescence-labeled secondary antibody (1:200) (Sigma-Aldrich; Merck KGaA) for 40 min at 37°C. 4′,6-diamidino-2-phenylindole (DAPI) was used to stain the nucleus of astrocytes at 37°C for 4 min and cell climbing samples were observed under a fluorescent microscope (Nikon Corporation, Tokyo, Japan).

Evaluation of cell viability by MTT analysis

Cell viability was measured by MTT assay. A total of 24 h following reoxygenation, 20 µl MTT solution was added (5 g/l) to the cell culture plate and after 4 h, 150 µl DMSO was added then oscillated for 10 min. Absorbance (A) value was measured by a microplate reader at a wavelength of 490 nm. Finally, according to the following formula, the relative cell viability can be calculated: Relative cell viability = experimental group/control group ×100%.

Evaluation of cell cytotoxicity by LDH analysis

A total of 24 h following oxygen-glucose deprivation/reoxygenation, cell cytotoxicity was measured by LDH assay. Each group had 20 µl cell culture fluid removed and LDH (U/l) was measured by colorimetry according to the protocol of the LDH assay kit. Finally, according to the following formula, the LDH leakage rate can be calculated: Relative cell cytotoxicity = experimental group (U/l)/control group (U/l) ×100%. Through MTT experiment and LDH experiment the ideal concentration of Cur was identified and the optimum concentration was used in the following experiments.

Western blot analysis

Radioimmunoprecipiration assay lysis solution (Beyotime Institute of Biotechnology) was used to lyse the cells at 0°C for 20 min, followed by centrifugation at 12,000 × g at 4°C for 10 min to collect protein supernatants. Using western blot analysis, the expression of MEK, p-MEK, ERK, p-ERK, CREB, p-CREB, Bcl-2 and Bax were measured. Samples (30 µl) were separated by 12% SDS-PAGE then transferred to a nitrocellulose membrane. The membrane was blocked with 10% goat serum at 25°C for 2 h and the anti-rabbit primary antibodies against MEK (cat. no. SAB4502407), p-MEK (cat. no. HPA026430), ERK (cat. no. M7927), p-ERK (cat. no. M7927), CREB (cat. no. SAB4500444), p-CREB (cat. no. AV01026), Bcl-2 (cat. no. SAB4500003), and anti-mouse antibodies against Bax (cat. no. B8554) and β-actin (cat. no. A5441) (1:1,000) were added to the membrane overnight at 4°C. After washing, the membranes were incubated with anti-rabbit HRP-conjugated secondary antibodies (cat. no. AP182P; 1:2,000) at 37°C for 40 min. Subsequently, the membranes were processed with an ECL kit to detect immune reactivity. Finally, images were analyzed with a Versa Doc Model 3000.

Statistical analysis

All data were expressed as the mean ± standard deviation of the mean and were analyzed by SPSS version 24.0 for Windows (IBM Corps., Armonk, NY, USA). A one-way analysis of variance was used to compare the difference of measurement data among multiple groups. The post hoc test was performed using Tukey’s post hoc method. The number of experimental repeats for each sample was 3. Pairwise comparisons in multiple groups was conducted with the Student-Newman-Keuls method. P<0.05 was considered to indicate a statistically significant difference.

Results

Cur can improve nerve damage symptoms in rats

A total of 24 h following ischemia/reperfusion, the neuroprotective effect of Cur was examined by evaluating neurological deficit scores and brain water content. As presented in Fig. 1, compared with the IR group, the IC group can significantly alleviate nerve damage symptoms (P<0.05), most notably in the IC group of 300 mg/kg.

Cur can improve brain water content of IR rats

A total of 24 h following ischemia/reperfusion, the effect of Cur was examined by investigating brain water content. The results demonstrated that Cur can reduce cerebral edema. As presented in Fig. 2, IC groups can significantly reduce the brain water content (P<0.05), particularly the IC group at a dose of 300 mg/kg. Through these two experiments, it was also demonstrated that neurological deficit scores and brain water content were decreased in a dose-dependent manner. In addition, only the IC group of 300 mg/kg were used in the rest of the experiments.

Cur can reduce the volume of a cerebral infarct in IR rats

A total of 24 h following ischemia/reperfusion, the infract volume was measured. As presented in Fig. 3, compared with the IR group, the IC group (IC, 300 mg/kg) displayed significantly decreased pale-colored regions (P<0.01).

Cur can improve neuronal damage in CA1 area by TEM

A total of 24 h following ischemia/reperfusion, changes in neurons were observed using TEM. As presented in Fig. 4, TEM of the SC group (magnification, ×6,000) displayed normal neuronal structure and no significant alterations. However TEM of the IR group (×6,000) revealed serious neuronal damage in the CA1 area, exhibiting nucleus electron density decreases, dissolution, cavitation, mitochondrial swelling and endoplasmic reticulum. Compared with the IR group, the IC group (300 mg/kg; magnification, ×6,000) exhibited less severe changes.

Cur can improve neuronal damage in the CA1 region as demonstrated by H&E staining

A total of 24 h following ischemia/reperfusion, the IR group displayed abnormal cell structures and morphology. Specifically, cell body and nucleus condensation, stained nucleoli, and gaps around the cells were observed. As presented in Fig. 5, compared with the IR group, the IC group (300 mg/kg) significantly reduced abnormal cells (P<0.01).

Cur can reduce neuronal apoptosis in the hippocampal CA1 region as demonstrated by TUNEL staining

A total of 24 h following ischemia/reperfusion, the TUNEL method was utilized to detect neuronal apoptosis of hippocampal CA1. In hippocampal CA1, normal cells were stained blue, but apoptotic cell nuclei were stained brown. As presented in Fig. 6, in the SC group, almost no TUNEL-positive cells were present in the hippocampal CA1 region. Compared with the SC group, the number of apoptotic cells in the IR group was significantly increased. However the IC group (300 mg/kg) displayed a significantly lower number of apoptotic cells (P<0.01).

Cur can increase the expression of p-MEK, MEK, p-ERK, ERK, p-CREB, CREB, Bcl-2 and reduce the expression of Bax in vivo

The expression of p-MEK, MEK, p-ERK, ERK, p-CREB, CREB, Bcl-2 and Bax were detected by western blotting 24 h following reperfusion in vivo. As presented in Fig. 7, it was demonstrated that the IC group (300 mg/kg) increased the expression of p-ERK, p-CREB, Bcl-2 and reduced the levels of Bax significantly (P<0.01).

Identification of astrocytes in vitro

Astrocytes were identified by immunofluorescence staining with astrocyte-specific marker GFAP antibody. Under a fluorescent microscope, a notable green fluorescence was visible in the cell cytoplasm and projections, and nuclei appeared blue by DAPI staining. Furthermore, cytons were large and irregular with few cell projections of GFAP-positive cells. These characteristics were consistent with the morphology of astrocytes and distribution characteristics of GFAP, demonstrating that astrocytes were present (Fig. 8).

Cur can increase the viability of astrocytes in vitro

A total of 24 h following oxygen-glucose deprivation/reoxygenation, the effect of Cur on the viability of astrocytes was examined. As presented in Fig. 9. compared with the OGD/Reoxy group, the OGD/Reoxy + C groups significantly increased the astrocytes’ viability (P<0.01), particularly the OGD/Reoxy + C group of 20 µmol/l.

Cur can reduce LDH leakage rates

Following oxygen-glucose deprivation/reoxygenation for 24 h, the effect of Cur on LDH leakage rates was examined. As presented in Fig. 10, compared with the OGD/Reoxy group, the OGD/Reoxy + C groups significantly reduced the LDH leakage rate (P<0.01), particularly the OGD/Reoxy + C group of 20 µmol/l. Therefore, only C-treatment group of 20 µmol/l was used in other experiments.

Cur can increase the expression of p-MEK, MEK, p-ERK, ERK, P-CREB, CREB, Bcl-2 and reduce the expression of Bax in vitro

The expression of p-MEK, MEK, p-ERK, ERK, p-CREB, CREB, Bcl-2 and Bax were detected by western blotting for 24 h following reperfusion in vitro. As presented in Fig. 11, the IC groups (20 µmol/l) increased the expression of p-MEK, MEK, p-ERK, ERK, p-CREB, CREB, Bcl-2 and reduced the Bax levels significantly compared with the IR group (P<0.01). These results were consistent with the experimental results in vivo.

Discussion

Glial cells were first identified by Rudolf Virchow in 1846 (21). In the years since, a wide range of research has been conducted on the morphology and function of glial cells, especially astrocytes. Astrocytes were proved not to be simply inert cells, in contrast, they serve a very important role in the development of the nervous system, nerve tissue repair and regeneration, nerve and immune pathogenesis (22,23).

There are also studies which indicate that activation of the MEK/ERK or ERK/CREB pathway may protect astrocytes from ischemic injury (24,25). Cur is known to have neuroprotective properties in cerebral ischemia-reperfusion injury. However, the underlying molecular mechanisms are still poorly understood. The main focus of this study are the in vivo experiments that utilize the artery occlusion model in rats, however the hypothesis was further confirmed by conducting experimental studies in vitro. To the best of our knowledge this study is the first to investigate the association between Cur and the MEK/ERK/CREB signaling pathway in cerebral ischemia-reperfusion.

There is significant evidence demonstrating that activation of the MEK-ERK1/2 signaling pathway has a neuroprotective effect in cerebral ischemia-reperfusion injury (26). Additionally Fu et al (23) also demonstrated that increasing the expression of p-CREB through MEK/ERK pathways can exert neuroprotective effects against ischemia. Previous studies have also confirmed that Bcl-2, BAD, CREB, glycogen synthesis kinase3 and brain-derived neurotrophic factor are the MEK/ERK pathway downstream targets, and they serve a very important role in neuronal survival, development and maintaining the plasticity of neurons (27-29) ERK may also improve microcirculation and reduce neuronal apoptosis.

CREB and the active form p-CREB, are important nuclear transcription factors, which serve an indispensable role in the nervous system (30) and CREB activation is a key factor in neuroprotection against ischemic reperfusion damage. During a stroke, a variety of apoptosis regulatory gene products are activated (31). Among them, Bcl-2 is an important anti-apoptotic proteins and Bax is an important pro-apoptotic protein (32,33). Enhancing Bcl-2 and reducing Bax have been demonstrated to promote cell survival and promote a neuroprotective effect following focal cerebral ischemia (34,35).

The present study suggests that Cur can improve neurological symptom scores and brain water content, (with the best effect at 300 mg/kg) and enhance the activation of MEK, ERK and CREB. The expression of downstream signaling molecules Bcl-2 is regulated by CREB. As indicated above, the expression of Bcl-2 was enhanced and Bax was reduced. The results of the TUNEL assay also verified the neuroprotective effects in terms of pathomorphology. In hippocampal CA1 of the rats, the results of TUNEL demonstrated that in the SC group, almost no TUNEL-positive cells were identified in the hippocampal CA1 region. However in the IR group, TUNEL-positive cells were increased. Following treatment with Cur (300 mg/kg), TUNEL-positive cells were reduced. The results of neurobehavioral scores, TEM and H&E, were also consistent with these findings.

In conclusion, Cur can protect rats from focal cerebral ischemia-reperfusion injury and this effect may be carried out through the MEK/ERK/CREB pathway.

Acknowledgments

The authors would like to thank Professor Zhi Dong for guidance and the Chongqing Medical University Laboratory of Biochemistry and Molecular Pharmacology for providing the platform for the experiment.

Funding

The present study was supported financially by the Chongqing Science and Technology Commission (grant nos. CSTC2016jcyjA0268, CSTC2018jcyjAX0821 and CSTC2018jxj1130009) and the Chongqing Medical and Pharmaceutical College Scientific Research Projects (grant no. ygz2018302).

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Authors’ contributions

YH and JL conceived and designed the study. LX, LD and YS performed the experiments. RS analyzed the data. LX wrote and revised the paper. YH and JL reviewed and edited the manuscript. All authors read and approved the manuscript.

Ethics approval and consent to participate

Experimental protocols were all approved by the Chongqing Medical and Pharmaceutical College’s Institutional Animal Care and Use Committee.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Durai Pandian J, Padma V, Vijaya P, Sylaja PN and Murthy JM: Stroke and thrombolysis in developing countries. Int J Stroke. 2:17–26. 2007. View Article : Google Scholar

2 

Moskowitz MA, Lo EH and Iadecola C: The science of stroke: Mechanisms in search of treatments. Neuron. 67:181–198. 2010. View Article : Google Scholar : PubMed/NCBI

3 

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, et al: Heart disease and stroke statistics-2018 update: A report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 137:e67–e492. 2018. View Article : Google Scholar

4 

Fogelholm R: Editorial comment-Explanations for international trends in stroke mortality. Stroke. 34:1833–1840. 2003. View Article : Google Scholar

5 

Nagahiro S, Uno M, Sato K, Goto S, Morioka M and Ushio Y: Pathophysiology and treatment of cerebral ischemia. J Med Invest. 45:57–70. 1998.PubMed/NCBI

6 

Bates B, Choi JY, Duncan PW, Glasberg JJ, Graham GD, Katz RC, Lamberty K, Reker D and Zorowitz R; US Department of Defense and Department of Veterans Affairs: Veterans affairs/department of defense clinical practice guideline for the management of adult stroke rehabilitation care: Executive summary. Stroke. 36:2049–2056. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Grotta J and Marler J: Intravenous rt-PA: A tenth anniversary reflection. Surg Neurol. 68:S12–S16. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Pan J, Konstas AA, Bateman B, Ortolano GA and Pile-Spellman J: Reperfusion injury following cerebral ischemia: Pathophysiology, MR imaging, and potential therapies. Neuroradiology. 49:93–102. 2007. View Article : Google Scholar :

9 

Minnerup J, Sutherland BA, Buchan AM and Kleinschnitz C: Neuroprotection for stroke: Current status and future perspectives. Int J Mol Sci. 13:11753–11772. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Love S: Apoptosis and brain ischaemia. Prog Neuropsy chopharmacol Biol Psychiatry. 27:267–282. 2003. View Article : Google Scholar

11 

Sugawara T, Fujimura M, Noshita N, Kim W, Saito A, Hayashi T, Narasimhan P, Maier CM and Chan Pak H: Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx. 1:17–25. 2004. View Article : Google Scholar

12 

Zhao Y, Gui W, Niu F and Chong S: The MAPK signaling pathways as a novel way in regulation and treatment of parasitic diseases. Disease. 7:E92019. View Article : Google Scholar

13 

Selcher JC, Atkins CM, Trzaskos JM, Paylor R and Sweatt JD: A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem. 6:478–490. 1999. View Article : Google Scholar : PubMed/NCBI

14 

Cheng CY, Lin JG, Su SY, Tang NY, Kao ST and Hsieh CL: Electroacupuncture-like stimulation at baihui and dazhui acupoints exerts neuroprotective effects through activation of the brain-derived neurotrophic factor-mediated MEK1/2/ERK/1/2/p90RSK/bad signaling pathway in mild transient focal cerebral ischemia in rats. BMC Complement Altern Med. 14:922014. View Article : Google Scholar

15 

Li J, Li X, Bi H and Li B: The MEK/ERK/CREB signaling pathway is involved in atrazine induced hippocampal neurotoxicity in sprague dawley rats. Ecotoxicol Environ Saf. 170:673–681. 2019. View Article : Google Scholar

16 

Zuo H, Lin T, Wang W, Peng R, Wang S, Gao Y, Xu X, Zhao L, Wang S and Su Z: RKIP regulates neural cell apoptosis induced by exposure to microwave radiation partly through the MEK/ERK/CREB pathway. Mol Neurobiol. 51:1520–1529. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Zhao X, Xu Y, Zhao Q, Chen CR, Liu AM and Huang ZL: Curcumin exerts antinociceptive effects in a mouse model of neuropathic pain: Descending monoamine system and opioid receptors are differentially involved. Neuropharmacology. 62:843–854. 2012. View Article : Google Scholar

18 

Kim KT, Kim MJ, Cho DC, Park SH, Hwang JH, Sung JK, Cho HJ and Jeon Y: The neuroprotective effect of treatment with curcumin in acute spinal cord injury: Laboratory investigation. Neurol Med Chir. 54:387–394. 2014. View Article : Google Scholar

19 

Gazal M, Valente MR, Acosta BA, Kaufmann FN, Braganhol E, Lencina CL, Stefanello FM, Ghisleni G and Kaster MP: Neuroprotective and antioxidant effects of curcumin in a ketamine-induced model of mania in rats. Eur J Pharmacol. 724:132–139. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:84–91. 1989. View Article : Google Scholar : PubMed/NCBI

21 

Nilsson M, Thorlin T, Blomstrand F and Hansson E: The star-shaped cells. Astrocytes are involved in the pathogenesis and progress of neurological diseases. Lakartidningen. 97:3604–3610. 2000.PubMed/NCBI

22 

Ridet JL, Malhotra SK, Privat A and Gage FH: Reactive astrocytes: Cellular and molecular cues to biological function. Trends Neurosci. 20:570–577. 1997. View Article : Google Scholar

23 

Fu J, Xue R, Gu J, Xiao Y, Zhong H, Pan X and Ran R: Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus. Mol Med Rep. 8:1708–1714. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Jiang Z, Zhang Y, Chen X, Lam PY, Yang H, Xu Q and Yu AC: Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem Biophys Res Commun. 294:726–733. 2002. View Article : Google Scholar : PubMed/NCBI

25 

Zhou B, Chen D, Xu H and Zhang X: Proliferation of rabbit chondrocyte and inhibitioof IL-1β-induced apoptosis through MEK/ERKsignaling by statins. In Vitro Cell Dev Biol Anim. 53:124–131. 2017. View Article : Google Scholar

26 

Yu Z, Cai M, Li X, Zhang J, Wu T, Yang F, Zhu W, Xiang Y, Zhang W, Xiang J and Cai D: Neuroprotective effects of Tongxinluo on focal cerebral ischemia and reperfusion injury inrats associated with the activation of the MEK1/2/ERK1/2/p90RSK signaling pathway. Brain Res. 1685:9–18. 2018. View Article : Google Scholar : PubMed/NCBI

27 

Huang EJ and Reichardt LF: Neurotrophins: Roles in neuronal development and function. Annu Rev Neurosci. 24:677–736. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Marinissen MJ and Gutkind JS: G-protein-coupled receptors and signaling. Networks: Emerging paradigms. Trends Pharmacol Sci. 22:368–376. 2001. View Article : Google Scholar : PubMed/NCBI

29 

Weeber EJ and Sweatt JD: Molecular neurobiology of human cognition. Neuron. 33:845–848. 2002. View Article : Google Scholar : PubMed/NCBI

30 

Sakamoto K, Karelina K and Obrietan K: CREB: A multifaceted regulator of neuronal plasticity and protection. J Neurochem. 116:1–9. 2011. View Article : Google Scholar

31 

Lipton P: Ischemic cell death in brain neurons. Physiol Rev. 79:1431–1568. 1999. View Article : Google Scholar : PubMed/NCBI

32 

Brambrink AM, Schneider A, Noga H, Astheimer A, Gotz B, Korner I, Heimann A, Welschof M and Kempski O: Tolerance-Inducing dose of 3-nitropropionic acid modulates bcl-2 and bax balance in the rat brain: A potential mechanism of chemical preconditioning. J Cereb Blood Flow Metab. 20:1425–1436. 2000. View Article : Google Scholar : PubMed/NCBI

33 

Ajami M, Eghtesadi S, Razaz JM, Kalantari N, Habibey R, Nilforoushzadeh MA, Zarrindast M and Pazoki-Toroudi H: Expression of Bcl-2 and Bax after hippocampal ischemia in DHA +EPA treated rats. Neurol Sci. 32:811–818. 2011. View Article : Google Scholar : PubMed/NCBI

34 

Zhu Y, Bu Q, Liu X, Hu W and Wang Y: Neuroprotective effect of TAT-14-3-3epsilon fusion protein against cerebral ischemia/reperfusion injury in rats. PLoS One. 9:e933342014. View Article : Google Scholar

35 

Boucher MJ, Duchesne C, Laine J, Morisset J and Rivard N: cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition. Biochem Biophys Res Commun. 285:207–216. 2001. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April-2019
Volume 43 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu L, Ding L, Su Y, Shao R, Liu J and Huang Y: Neuroprotective effects of curcumin against rats with focal cerebral ischemia-reperfusion injury. Int J Mol Med 43: 1879-1887, 2019.
APA
Xu, L., Ding, L., Su, Y., Shao, R., Liu, J., & Huang, Y. (2019). Neuroprotective effects of curcumin against rats with focal cerebral ischemia-reperfusion injury. International Journal of Molecular Medicine, 43, 1879-1887. https://doi.org/10.3892/ijmm.2019.4094
MLA
Xu, L., Ding, L., Su, Y., Shao, R., Liu, J., Huang, Y."Neuroprotective effects of curcumin against rats with focal cerebral ischemia-reperfusion injury". International Journal of Molecular Medicine 43.4 (2019): 1879-1887.
Chicago
Xu, L., Ding, L., Su, Y., Shao, R., Liu, J., Huang, Y."Neuroprotective effects of curcumin against rats with focal cerebral ischemia-reperfusion injury". International Journal of Molecular Medicine 43, no. 4 (2019): 1879-1887. https://doi.org/10.3892/ijmm.2019.4094